InVivo Therapeutics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

You can watch NVIV and buy or sell other stocks, options, and ETFs commission-free!

About NVIV

Invivo Therapeutics Holdings Corp. operates as a research and clinical-stage biotechnology company, which engages in developing and commercializing biopolymer scaffolding devices for the treatment of spinal cord injuries. Its clinical development program is the Neuro-Spinal Scaffold implant, which is an investigational bioresorbable polymer scaffold that is designed for implantation at the site of injury within a spinal cord. 

CEO
Richard Toselli
CEORichard Toselli
Employees
6
Employees6
Headquarters
Cambridge, Massachusetts
HeadquartersCambridge, Massachusetts
Founded
2005
Founded2005
Employees
6
Employees6

NVIV Key Statistics

Market cap
3.63M
Market cap3.63M
Price-Earnings ratio
Price-Earnings ratio
Dividend yield
Dividend yield
Average volume
1.40M
Average volume1.40M
High today
High today
Low today
Low today
Open price
Open price
Volume
0.00
Volume0.00
52 Week high
$1.74
52 Week high$1.74
52 Week low
$0.1231
52 Week low$0.1231
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.